Dr. Gil I. Wolfe, MD
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Years since graduation
- 37
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 118
Licensed in Texas since 1990, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
NY license 264033 · TX license H7677 (first issued 1990; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Kaleida Health Buffalo, NY
- White Plains Hospital Center White Plains, NY
- Stamford Hospital Stamford, CT
- St Vincent's Medical Center Bridgeport, CT
- Erie County Medical Center Buffalo, NY
Medical groups
- University Neurology, Inc (36 clinicians)
- Neurophysiologic Interpretive Medicine PLLC (12 clinicians)
- Neurophysiologic Interpretive Specialists LLC (11 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 118
- Services billed
- 4,797
- Patients’ average age
- 69
| Service | Times | Patients |
|---|---|---|
| Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | 892 | 102 |
| Placement of skin electrodes and measurement of stimulated sites on arms and legs | 105 | 104 |
| Needle measurement of electrical activity in arm, leg, trunk or head muscles, limited study | 80 | 35 |
| Needle measurement of electrical activity in arm or leg muscles, 2 extremities | 44 | 44 |
| Placement of skin electrodes and measurement of central motor stimulation in arms and legs | 41 | 41 |
| Needle measurement of electrical activity in arm or leg muscles, limited study | 32 | 15 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 26 | 13 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 18 | 18 |
| Nerve conduction, 3-4 studies | 11 | 11 |
| Measurement of brain wave activity (eeg), in coma or asleep | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Pyridostigmine Bromide Other prescribers in Buffalo, NY | 47 |
| Prednisone Other prescribers in Buffalo, NY | 41 |
| Gabapentin Other prescribers in Buffalo, NY | 29 |
| Mycophenolate Mofetil Other prescribers in Buffalo, NY | 24 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 15 companies reported 96 payments worth $107,597 in total to this clinician.
| UCB SA | $24,678 |
|---|---|
| Grifols USA, LLC | $23,678 |
| Janssen Biotech, Inc. | $13,303 |
| UCB, Inc. | $11,636 |
| Janssen Global Services, LLC | $11,280 |
| Alexion Pharmaceuticals, Inc. | $8,360 |
| Novartis Pharmaceuticals Corporation | $4,157 |
| Argenx US, Inc. | $3,421 |
| Consulting Fee | $49,647 |
|---|---|
| Compensation for services other than consulting (speaking, faculty) | $31,261 |
| Travel and Lodging | $21,508 |
| Honoraria | $3,300 |
| Food and Beverage | $1,882 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| UCB SA Oct 16, 2025 | Travel and Lodging travel to Barcelona, Spain · in-kind | $13,722 |
| Janssen Global Services, LLC Jan 13, 2025 | Consulting Fee | $11,280 |
| Grifols USA, LLC Nov 22, 2025 | Consulting Fee Gamunex-C · Immunology and Neurology | $10,000 |
| UCB SA Nov 28, 2025 | Consulting Fee | $8,320 |
| UCB, Inc. Oct 24, 2025 | Consulting Fee Rystiggo · Neurology | $6,720 |
| Janssen Biotech, Inc. Dec 13, 2025 | Compensation for services other than consulting (speaking, faculty) | $4,935 |
| Alexion Pharmaceuticals, Inc. Sep 18, 2025 | Compensation for services other than consulting (speaking, faculty) ULTOMIRIS · Rare Disease Company’s descriptionSpeaker Fee | $4,720 |
| Novartis Pharmaceuticals Corporation Jun 18, 2025 | Consulting Fee | $4,125 |
| Grifols USA, LLC Sep 3, 2025 | Compensation for services other than consulting (speaking, faculty) Gamunex-C · Immunology and Neurology | $3,920 |
| Grifols USA, LLC Dec 1, 2025 | Compensation for services other than consulting (speaking, faculty) Gamunex-C · Immunology and Neurology | $3,920 |
All 60 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| UCB, Inc. Dec 26, 2025 | Consulting Fee Rystiggo · Neurology | $1,040 |
| Janssen Biotech, Inc. Dec 17, 2025 | Travel and Lodging travel to DALLAS, TX | $19.37 |
| Janssen Biotech, Inc. Dec 17, 2025 | Travel and Lodging travel to DALLAS, TX | $14.00 |
| Janssen Biotech, Inc. Dec 13, 2025 | Compensation for services other than consulting (speaking, faculty) | $4,935 |
| Janssen Biotech, Inc. Dec 13, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,173 |
| Argenx US, Inc. Dec 12, 2025 | Consulting Fee VYVGART; VYVGART HYTRULO · Immunology | $1,250 |
| Janssen Biotech, Inc. Dec 11, 2025 | Travel and Lodging travel to DALLAS, TX · in-kind | $1,150 |
| Janssen Biotech, Inc. Dec 11, 2025 | Travel and Lodging travel to DALLAS, TX · in-kind | $467 |
| Janssen Biotech, Inc. Dec 11, 2025 | Travel and Lodging travel to DALLAS, TX · in-kind | $169 |
| UCB, Inc. Dec 4, 2025 | Compensation for services other than consulting (speaking, faculty) Zilbrysq · Neurology | $1,300 |
| Grifols USA, LLC Dec 1, 2025 | Compensation for services other than consulting (speaking, faculty) Gamunex-C · Immunology and Neurology | $3,920 |
| Grifols USA, LLC Dec 1, 2025 | Travel and Lodging Gamunex-C · Immunology and Neurology · travel to Roslyn, NY · in-kind | $295 |
| Grifols USA, LLC Dec 1, 2025 | Travel and Lodging Gamunex-C · Immunology and Neurology · travel to Roslyn, NY · in-kind | $239 |
| Grifols USA, LLC Dec 1, 2025 | Travel and Lodging Gamunex-C · Immunology and Neurology · travel to Roslyn, NY | $171 |
| Grifols USA, LLC Dec 1, 2025 | Travel and Lodging Gamunex-C · Immunology and Neurology · travel to Roslyn, NY | $4.00 |
| UCB SA Nov 28, 2025 | Consulting Fee | $8,320 |
| Grifols USA, LLC Nov 22, 2025 | Consulting Fee Gamunex-C · Immunology and Neurology | $10,000 |
| Grifols USA, LLC Nov 22, 2025 | Travel and Lodging Gamunex-C · Immunology and Neurology · travel to Raleigh, NC · in-kind | $496 |
| Grifols USA, LLC Nov 22, 2025 | Travel and Lodging Gamunex-C · Immunology and Neurology · travel to Raleigh, NC · in-kind | $415 |
| Grifols USA, LLC Nov 22, 2025 | Travel and Lodging Gamunex-C · Immunology and Neurology · travel to Raleigh, NC | $85.05 |
| Argenx US, Inc. Nov 20, 2025 | Consulting Fee VYVGART · Immunology | $1,313 |
| Argenx US, Inc. Nov 13, 2025 | Travel and Lodging VYVGART HYTRULO · Neurology · travel to San Francisco, CA | $15.78 |
| Grifols USA, LLC Oct 29, 2025 | Compensation for services other than consulting (speaking, faculty) Gamunex-C · Immunology and Neurology | $1,425 |
| UCB, Inc. Oct 24, 2025 | Consulting Fee Rystiggo · Neurology | $6,720 |
| UCB, Inc. Oct 24, 2025 | Travel and Lodging Rystiggo · Neurology · travel to Boston, MA | $13.83 |
| UCB, Inc. Oct 24, 2025 | Travel and Lodging Rystiggo · Neurology · travel to Boston, MA | $12.60 |
| UCB, Inc. Oct 24, 2025 | Travel and Lodging Rystiggo · Neurology · travel to Boston, MA | $4.80 |
| UCB SA Oct 16, 2025 | Travel and Lodging travel to Barcelona, Spain · in-kind | $13,722 |
| UCB SA Oct 16, 2025 | Travel and Lodging travel to Barcelona, Spain · in-kind | $1,356 |
| Janssen Biotech, Inc. Oct 11, 2025 | Compensation for services other than consulting (speaking, faculty) | $1,410 |
| UCB, Inc. Oct 3, 2025 | Travel and Lodging Rystiggo · Neurology · travel to Boston, MA · in-kind | $430 |
| UCB, Inc. Oct 3, 2025 | Travel and Lodging Rystiggo · Neurology · travel to Boston, MA · in-kind | $197 |
| UCB, Inc. Oct 2, 2025 | Compensation for services other than consulting (speaking, faculty) Rystiggo · Neurology | $1,300 |
| Alexion Pharmaceuticals, Inc. Sep 18, 2025 | Compensation for services other than consulting (speaking, faculty) ULTOMIRIS · Rare Disease Company’s descriptionSpeaker Fee | $4,720 |
| Alexion Pharmaceuticals, Inc. Sep 18, 2025 | Compensation for services other than consulting (speaking, faculty) ULTOMIRIS · Rare Disease Company’s descriptionSpeaker Fee | $1,770 |
| Grifols USA, LLC Sep 17, 2025 | Compensation for services other than consulting (speaking, faculty) Gamunex-C · Immunology and Neurology | $1,425 |
| UCB SA Sep 12, 2025 | Consulting Fee | $1,280 |
| Alexion Pharmaceuticals, Inc. Sep 10, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Greenville, SC · in-kind Company’s descriptionSpeaker Expenses | $63.00 |
| Alexion Pharmaceuticals, Inc. Sep 10, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Buffalo, NY | $28.01 |
| Alexion Pharmaceuticals, Inc. Sep 10, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Buffalo, NY | $14.00 |
| Alexion Pharmaceuticals, Inc. Sep 9, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Greenville, SC · in-kind Company’s descriptionSpeaker Expenses | $504 |
| Alexion Pharmaceuticals, Inc. Sep 9, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Greenville, SC · in-kind Company’s descriptionSpeaker Expenses | $391 |
| Alexion Pharmaceuticals, Inc. Sep 9, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Anderson, SC · in-kind Company’s descriptionSpeaker Expenses | $286 |
| Alexion Pharmaceuticals, Inc. Sep 9, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Greenville, SC · in-kind Company’s descriptionSpeaker Expenses | $168 |
| Alexion Pharmaceuticals, Inc. Sep 9, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Greenville, SC · in-kind Company’s descriptionSpeaker Expenses | $21.00 |
| Grifols USA, LLC Sep 3, 2025 | Compensation for services other than consulting (speaking, faculty) Gamunex-C · Immunology and Neurology | $3,920 |
| Grifols USA, LLC Sep 3, 2025 | Travel and Lodging Gamunex-C · Immunology and Neurology · travel to Edison, NJ · in-kind | $339 |
| Grifols USA, LLC Sep 3, 2025 | Travel and Lodging Gamunex-C · Immunology and Neurology · travel to Edison, NJ · in-kind | $243 |
| Grifols USA, LLC Sep 3, 2025 | Travel and Lodging Gamunex-C · Immunology and Neurology · travel to Edison, NJ | $109 |
| Grifols USA, LLC Sep 3, 2025 | Travel and Lodging Gamunex-C · Immunology and Neurology · travel to Edison, NJ | $10.58 |
| H. Lundbeck A S Sep 2, 2025 | Honoraria | $2,700 |
| UCB, Inc. Aug 26, 2025 | Travel and Lodging Rystiggo · Neurology · travel to Boston, MA · in-kind | $55.00 |
| UCB, Inc. Aug 5, 2025 | Compensation for services other than consulting (speaking, faculty) Zilbrysq · Neurology | $200 |
| Janssen Biotech, Inc. Aug 2, 2025 | Compensation for services other than consulting (speaking, faculty) | $1,763 |
| Argenx US, Inc. Jul 25, 2025 | Consulting Fee | $781 |
| Grifols Shared Services North America, Inc. Jun 30, 2025 | Consulting Fee Gamunex-C · Immunology and Neurology | $2,298 |
| Novartis Pharmaceuticals Corporation Jun 18, 2025 | Consulting Fee | $4,125 |
| Merck Kgaa May 28, 2025 | Consulting FeeCompany’s descriptionConsulting Services (Fee For Service) | $1,240 |
| H. Lundbeck A S Jan 15, 2025 | Honoraria | $600 |
| Janssen Global Services, LLC Jan 13, 2025 | Consulting Fee | $11,280 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $37,311 in research payments for these studies, mostly to the institutions running them.
- Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis
UCB SA · Completed · NCT04225871
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.